Lv5
1110 积分 2025-01-08 加入
Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trial
3天前
已完结
Abatacept in early polymyalgia rheumatica (ALORS): a proof-of-concept, randomised, placebo-controlled, parallel-group trial
3天前
已关闭
Abatacept in the treatment of adult dermatomyositis and polymyositis: a randomised, phase IIb treatment delayed-start trial
6天前
已完结
Treatment of active ankylosing spondylitis with abatacept: an open-label, 24-week pilot study
7天前
已完结
Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial
8天前
已完结
CAR T-cell therapy in systemic sclerosis: the next frontier in immune modulation
1个月前
已完结
[Recommendations for diagnosis and treatment of systemic sclerosis in China]
2个月前
已完结
In vivo CAR-Ts captivate big pharma
2个月前
已完结
Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria
2个月前
已完结
CAR-T cells drive into progressive multiple sclerosis
3个月前
已完结
皖公网安备34019202002308
